Study of RMC-6236 in Combination with Cetuximab with or without mFOLFOX6 in Patients with Unresectable or Metastatic Colorectal Cancer or Metastatic Pancreatic Ductal Adenocarcinoma - Subprotocol B
Clinical Trial Grant
Awarded By
Revolution Medicines, Inc
Start Date
November 14, 2024
End Date
November 26, 2029
Awarded By
Revolution Medicines, Inc
Start Date
November 14, 2024
End Date
November 26, 2029